1143P Nivolumab and ipilimumab (N+I) is active in patients (pts) with metastatic uveal melanoma (mUM) with extra-hepatic only involvement: Pooled analysis from 2 phase II trials
| Autor: | Rodriguez, J.M. Piulats, Patel, S., Espinosa, E., Pelster, M.S., Merino, L. de la Cruz, Khoja, L.T., Joshua, A.M., Tebe, C., Berrocal, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S764-S764 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|